HomeAI · summaries
Storia in 4 fonti
Novartis, Antares Partner To Pursue Undruggable Cancer Targets In $1.9 Billion Deal - Novartis (NYSE:NVS)
Antares inks Novartis collaboration worth up to $1.9 billion to develop therapies targeting hard-to-treat cancers.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Antares Therapeutics Enters Agreement with Novartis to Discover, Develop and Commercialize First-in-Class Cancer Therapies
Antares Therapeutics Enters Agreement with Novartis to Discover, Develop and Commercialize First-in-Class Cancer Therapies
- ·
endpoints.news
Novartis taps Antares in small molecule discovery pact with $105M upfront
Antares Therapeutics inks $105M upfront deal with Novartis to discover small molecules against undruggable cancer targets, with up to $1.8B in milestones.
